Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Pyrotech Therapeutics, Inc.

Clinical trials sponsored by Pyrotech Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New investigational drug PTT-121: a first step toward future therapies? Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 2

Can a new Immune-Boosting pill make immunotherapy work better against Hard-to-Treat tumors?

Disease control Recruiting now

This study tests an experimental drug called PTT-936, which activates a protein (ALPK1) that may help the immune system attack cancer. The trial includes adults with advanced or metastatic solid tumors that cannot be removed by surgery. In the first part, patients receive PTT-936…

Phase 1/2 • Sponsor: Pyrotech Therapeutics, Inc. • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC